Stock 600422 KPC PHARMACEUTICALS,INC
Add to a list
To use this feature you must be a member
Log inSign up

Company KPC Pharmaceuticals,Inc

Equities

600422

CNE0000015P8

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
22.53 CNY +2.41% Intraday chart for KPC Pharmaceuticals,Inc +5.33% +8.01%
Apr. 19 KPC Pharmaceuticals,Inc Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 17 Kunyao Group Receives Clinical Trial Approval for FMF Drug MT

Business Summary

KPC Pharmaceuticals, Inc. is a China-based company principally engaged in the research and development, manufacturing and sales of pharmaceuticals. The Company's main products include natural herbal medicines, traditional Chinese medicines and chemical synthetic drugs, such as central nervous system drugs, cardiovascular and cerebrovascular drugs, anti-parasitic drugs, anti-microbial drugs, anti-gout drugs, hormones and endocrine drugs, hemorrhoids medicines and anti-inflammatory drugs, among others. The Company is also engaged in the production of health products and provision of medical services.

Number of employees: 5,051

Sales per Business

CNY in Million2022Weight2023Weight Delta
Wholesale and Retail of Medicines and Equipment
43.1 %
3,587 43.3 % 3,322 43.1 % -7.40%
Cardiovascular and Cerebrovascular Treatment Areas
27.0 %
1,829 22.1 % 2,079 27.0 % +13.67%
Others
12.5 %
912 11.0 % 962 12.5 % +5.49%
Digestive System
7.0 %
572 6.9 % 535 7.0 % -6.36%
Gynecology
4.3 %
275 3.3 % 332 4.3 % +20.61%
Orthopedics Series
2.8 %
235 2.8 % 218 2.8 % -7.34%
Other Business
2.1 %
562 6.8 % 163 2.1 % -70.96%
Anti-malaria
1.2 %
111 1.3 % 91 1.2 % -18.03%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.4 %
7,569 98.1 % 7,574 98.4 % +0.07%
Abroad
1.5 %
150 1.9 % 117 1.5 % -22.39%
Hong Kong
0.1 %
-- 10 0.1 % -

Managers

Managers TitleAgeSince
Zhi Qiang Sun DFI
 Director of Finance/CFO - 23-01-02
Wei Yan PSD
 President 53 23-01-18
Wen Sen Zhang BRD
 Director/Board Member 52 97-08-31
Yu Dong IRC
 Investor Relations Contact 35 -
Meng Xun Zhang SEC
 Corporate Secretary 46 20-01-31
Li Meng PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Hua Wei Qiu CHM
 Chairman 57 23-01-18
Jin Guo Xin BRD
 Director/Board Member 62 09-10-31
Hui Zhou BRD
 Director/Board Member 53 23-10-17
Lin Xi Li BRD
 Director/Board Member 48 99-06-30
Kang Deng BRD
 Director/Board Member 39 21-04-28
Zheng Liang BRD
 Director/Board Member 46 23-01-18
Ke Liu BRD
 Director/Board Member 72 18-11-01
Wen Sen Zhang BRD
 Director/Board Member 52 97-08-31
Zhi Yang BRD
 Director/Board Member 64 21-12-07
Jiang Zhong CHM
 Chairman 49 23-01-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 757,113,997 470,609,734 ( 62.16 %) 138,240 ( 0.0183 %) 62.16 %

Shareholders

NameEquities%Valuation
CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.
28.05 %
212,311,616 28.05 % 632 M ¥
Government of China
7.924 %
59,982,730 7.924 % 179 M ¥
Zhong Ou Asset Management Co., Ltd
5.318 %
40,257,063 5.318 % 120 M ¥
ICBC Credit Suisse Asset Management Co., Ltd.
5.115 %
38,716,880 5.115 % 115 M ¥
First Seafront Fund Management Co., Ltd.
2.121 %
16,052,334 2.121 % 48 M ¥
Shi Hui Chen
2.090 %
15,820,881 2.090 % 47 M ¥
China Investment Corp. (Investment Management)
1.561 %
11,814,900 1.561 % 35 M ¥
Holley Group Co., Ltd.
1.506 %
11,399,854 1.506 % 34 M ¥
Fullgoal Fund Management Co., Ltd.
1.397 %
10,577,847 1.397 % 31 M ¥
China Southern Asset Management Co., Ltd.
0.9895 %
7,490,182 0.9895 % 22 M ¥
NameEquities%Valuation
Xiang Gang Zhong
26.00 %
332,812 26.00 % 990 498 ¥
Jun Feng Liu
12.00 %
153,600 12.00 % 457 137 ¥
Zhen Bo Hu
11.00 %
140,800 11.00 % 419 042 ¥
Lei Wang
11.00 %
140,800 11.00 % 419 042 ¥
Li Meng
10.000 %
128,000 10.000 % 380 947 ¥
Xiao Ru Qu
10.000 %
128,000 10.000 % 380 947 ¥
Bo Xie
5.000 %
64,000 5.000 % 190 474 ¥
Meng Xun Zhang
5.000 %
64,000 5.000 % 190 474 ¥

Company contact information

KPC Pharmaceuticals, Inc.

166 Keyi Road National High-Tech Indl Dev Zone

650106, Kunming

+86 871 6831 9868

http://www.kpc.com.cn
address KPC Pharmaceuticals,Inc(600422)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for KPC Pharmaceuticals,Inc

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
22.53 CNY
Average target price
25.01 CNY
Spread / Average Target
+11.01%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
KPC PHARMACEUTICALS,INC Stock KPC Pharmaceuticals,Inc
+8.01% 2.35B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600422 Stock
  4. Company KPC Pharmaceuticals,Inc